Literature DB >> 25914377

A Role for Gut Microbiota and the Metabolite-Sensing Receptor GPR43 in a Murine Model of Gout.

Angélica T Vieira1, Laurence Macia2, Izabela Galvão3, Flaviano S Martins3, Maria Cecília C Canesso2, Flávio A Amaral3, Cristiana C Garcia3, Kendle M Maslowski4, Ellen De Leon4, Doris Shim4, Jacques R Nicoli3, Jacquie L Harper5, Mauro M Teixeira3, Charles R Mackay2.   

Abstract

OBJECTIVE: Host-microbial interactions are central in health and disease. Monosodium urate monohydrate (MSU) crystals cause gout by activating the NLRP3 inflammasome, leading to interleukin-1β (IL-1β) production and neutrophil recruitment. This study was undertaken to investigate the relevance of gut microbiota, acetate, and the metabolite-sensing receptor GPR43 in regulating inflammation in a murine model of gout.
METHODS: Gout was induced by the injection of MSU crystals into the knee joints of mice. Macrophages from the various animals were stimulated to determine inflammasome activation and production of reactive oxygen species (ROS).
RESULTS: Injection of MSU crystals caused joint inflammation, as seen by neutrophil influx, hypernociception, and production of IL-1β and CXCL1. These parameters were greatly decreased in germ-free mice, mice treated with antibiotics, and GPR-43-deficient mice. Recolonization or administration of acetate to germ-free mice restored inflammation in response to injection of MSU crystals. In vitro, macrophages produced ROS and assembled the inflammasome when stimulated with MSU. Macrophages from germ-free animals produced little ROS, and there was little inflammasome assembly. Similar results were observed in macrophages from GPR-43-deficient mice. Treatment of germ-free mice with acetate restored in vitro responsiveness of macrophages to MSU crystals.
CONCLUSION: In the absence of microbiota, there is decreased production of short-chain fatty acids that are necessary for adequate inflammasome assembly and IL-1β production in a manner that is at least partially dependent on GPR43. These results clearly show that the commensal microbiota shapes the host's ability to respond to an inflammasome-dependent acute inflammatory stimulus outside the gut.
© 2015, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25914377     DOI: 10.1002/art.39107

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  74 in total

Review 1.  Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.

Authors:  Shivani Ghaisas; Joshua Maher; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2015-11-26       Impact factor: 12.310

2.  Editorial: Can GPR43 Sensing of Short-Chain Fatty Acids Unchain Inflammasome-Driven Arthritis?

Authors:  Alexander Haslberger; Robert Terkeltaub
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

3.  A gut feeling about immunity.

Authors:  Roxanne Khamsi
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

Review 4.  Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology.

Authors:  Medha Priyadarshini; Kumar U Kotlo; Pradeep K Dudeja; Brian T Layden
Journal:  Compr Physiol       Date:  2018-06-18       Impact factor: 9.090

5.  [The microbiome in rheumatic diseases : Driving force or confusing factor?]

Authors:  U Müller-Ladner
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

6.  Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection.

Authors:  Kevin Rey; Sukhbir Manku; Winnie Enns; Thea Van Rossum; Kevin Bushell; Ryan D Morin; Fiona S L Brinkman; Jonathan C Choy
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

7.  Metabolic characteristics and renal dysfunction in 65 patients with tophi prior to gout.

Authors:  Chuan-Chin Lu; Shyi-Kuen Wu; Wei-Sheng Chung; Liang-Hung Lin; Ta-Wei Hung; Chih-Jung Yeh
Journal:  Clin Rheumatol       Date:  2017-05-10       Impact factor: 2.980

Review 8.  Gut microbiota, metabolites and host immunity.

Authors:  Michelle G Rooks; Wendy S Garrett
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

Review 9.  Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.

Authors:  Mingming Sun; Wei Wu; Zhanju Liu; Yingzi Cong
Journal:  J Gastroenterol       Date:  2016-07-23       Impact factor: 7.527

Review 10.  The intersection of cell death and inflammasome activation.

Authors:  James E Vince; John Silke
Journal:  Cell Mol Life Sci       Date:  2016-04-11       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.